Skip to main content

Table 1 The eight identified immune clusters in prostate cancer

From: Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy

 

Genes

Number of Patients 430 (86.34%)

Cluster 1

232

129 (25.9%)

Cluster 2

314

44 (10.2%)

Cluster 3

276

52 (12.1%)

Cluster 4

129

56 (13.0%)

Cluster 5

116

43 (10.0%)

Cluster 6

27

49 (11.4%)

Cluster 7

111

28 (6.5%)

Cluster 8

52

29 (6.7%)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us